AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 285 filers reported holding AMEDISYS INC in Q3 2023. The put-call ratio across all filers is 10.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,127,312 | +2.1% | 33,483 | 0.0% | 0.20% | +81.2% |
Q2 2023 | $3,061,686 | +14.7% | 33,483 | -7.7% | 0.11% | +80.6% |
Q1 2023 | $2,668,835 | -16.5% | 36,286 | -5.1% | 0.06% | +12.7% |
Q4 2022 | $3,195,572 | -0.4% | 38,252 | +15.4% | 0.06% | 0.0% |
Q3 2022 | $3,209,000 | -50.5% | 33,153 | -11.9% | 0.06% | -56.3% |
Q1 2022 | $6,484,000 | -14.0% | 37,635 | -19.2% | 0.13% | -36.4% |
Q4 2021 | $7,536,000 | +96.7% | 46,550 | +81.2% | 0.20% | +182.9% |
Q3 2021 | $3,831,000 | -70.9% | 25,695 | -52.2% | 0.07% | -70.8% |
Q2 2021 | $13,177,000 | -32.7% | 53,800 | -27.3% | 0.24% | -28.4% |
Q1 2021 | $19,589,000 | -9.7% | 73,978 | 0.0% | 0.34% | -15.2% |
Q4 2020 | $21,700,000 | +24.1% | 73,978 | 0.0% | 0.40% | -24.3% |
Q3 2020 | $17,491,000 | +19.1% | 73,978 | 0.0% | 0.52% | -25.6% |
Q2 2020 | $14,688,000 | – | 73,978 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
RK Capital | 54,900 | $9,459,000 | 1.86% |
Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |